Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity

ABSTRACTPurpose:To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).Methods:Medical records of 40 infants were retrospectively reviewed. Group I included infants who had received IVB injections for APROP. Gro...

Full description

Bibliographic Details
Main Authors: Murat Gunay, Gokhan Celik, Betul Onal Gunay, Alev Aktas, Guner Karatekin, Fahri Ovali
Format: Article
Language:English
Published: Conselho Brasileiro de Oftalmologia 2015-10-01
Series:Arquivos Brasileiros de Oftalmologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000550079&lng=en&tlng=en